BPC-157 (Body Protection Compound-157) upregulates vascular endothelial growth factor (VEGF) and drives angiogenesis, the construction of new blood vessels at the injury site
We have a lead compound that we really want to explore, because it does, in fact, interact with a viral protein in the way that we predicted it to interact, so it has a chance of inhibiting viral entry into a host cell, says Brad Pentelute, an MIT associate professor of chemistry, who is leading the research team
It's not that it can't work or whatever, but I always look for things that are applicable
While many individuals experience benefits within hours or days of receiving an injection, the full spectrum of advantages may unfold over several weeks
Most reconstitution issues trace back to skipping prep, rushing injection speed, or poor labeling